EW - Edwards Lifesciences Corporation
| Previous Close | 113.08 |
| Open | 113.55 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 113.00 - 114.94 |
| 52 Week Range | 81.12 - 121.45 |
| Volume | 2,004,567 |
| Avg. Volume | 1,295,056 |
| Market Cap | 24.1B |
| Beta | 0.78 |
| PE Ratio (TTM) | 34.61 |
| EPS (TTM) | 3.3 |
| Earnings Date | Oct 24, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 130.80 |
- CNBC Videos•7 days ago
Nike among today's IQ100 leaders
The CNBC IQ100 index beating the broader market over one year up 26%. Today's leaders include UnitedHealth, Johnson & Johnson, Nike and Edwards Lifesciences.
- CNBC Videos•20 days ago
Cramer's lightning round: Promotional activity works for ...
Jim Cramer rattles off his take on callers' favorite stocks, including an old-line children's apparel play.
- Zacks•7 hours ago
This Week's Spectacular Big Cap Earnings Charts
Wall Street is in love with large cap stocks and these 5 companies have some of the best earnings charts this week.
- Capital Cube•16 hours ago
Edwards Lifesciences Corp. – Value Analysis (NYSE:EW) : October 23, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Edwards Lifesciences Corp. a score of 75. Our analysis is based on comparing Edwards Lifesciences Corp. with the following peers – Boston Scientific Corporation, C. R. Bard, Inc., Merit Medical Systems, Inc., LeMaitre Vascular, Inc., Dextera Surgical, Inc., ICU Medical, Inc., Medtronic plc and CryoLife, Inc. (BSX-US, ... Read more (Read more...)
- Zacks•18 hours ago
EW vs. BCR: Which Stock is Poised for Better Q3 Earnings?
Political turmoil and the health policy related battle apart, majority of the MedTech stocks' bottom line is likely to be hurt in the third quarter on escalating costs induced by consecutive hurricanes and Mexico earthquakes.
- Capital Cube•4 days ago
Edwards Lifesciences Corp. breached its 50 day moving average in a Bullish Manner : EW-US : October 20, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Edwards Lifesciences Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
- Zacks•6 days ago
Will Edwards Lifesciences (EW) Gain on THVT in Q3 Earnings?
Edwards Lifesciences (EW) will likely ride high in Q3 earnings banking on continued growth in its highly advanced Transcatheter Heart Valve Therapy space.
Markit•6 days agoSee what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
Edwards Lifesciences Corp NYSE:EW
- Market Realist•8 days ago
Edwards Lifesciences Stock Gaining Momentum: What’s Next?
Edwards Lifesciences (EW) was trading at a high of $110.60 on October 12, 2017. The stock closed the day at $110.20.
- Market Realist•8 days ago
Analysts’ Recommendations for Edwards Lifesciences before 3Q17
As of October 13, 2017, according to a Reuters survey consisting of 22 brokerage firms, 77.3% of the firms rated Edwards Lifesciences a "buy.”
- Market Realist•10 days ago
Edwards Lifesciences’ Earnings Forecast for 3Q17
According to Wall Street analysts’ estimates, Edwards Lifesciences’ fiscal 3Q17 EPS is expected to be $0.86.
- Market Realist•10 days ago
Edwards Lifesciences: Analysts Expect 12.5% 3Q17 Revenue Growth
According to Wall Street analysts’ estimates for 3Q17, Edwards Lifesciences is expected to have revenues of $8.3 billion, a YoY (year-over-year) sales growth of 12.5%.
- Market Realist•11 days ago
What to Expect from Edwards Lifesciences’ Fiscal 3Q17 Results
Edwards Lifesciences (EW) has scheduled its 3Q17 earnings release for October 24, 2017. This leading player in the artificial heart valves market has been gaining momentum and trading near its 52-week ...
- PR Newswire•12 days ago
Edwards Lifesciences To Host Earnings Conference Call On October 24, 2017
IRVINE, Calif. , Oct. 11, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans ...
Markit•15 days agoSee what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting EW. Over the last one-month, outflows of investor capital in ETFs holding EW totaled $5.84 billion.
- Motley Fool•16 days ago
3 Top Med-Tech Stocks You Can Buy Right Now
Medical technology might be hotter than you think.
- Zacks•22 days ago
Edwards Lifesciences Pipeline Impressive, Currency Woes Stay
Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.
- Zacks•26 days ago
Medtronic (MDT) Initiates Study on CoreValve Evolut PRO TAVI
Medtronic (MDT) to initiate FORWARD PRO Clinical Study for evaluating the safety standards of self-expanding TAVI system over longer-term.
Markit•27 days agoSee what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting EW. Over the last one-month, outflows of investor capital in ETFs holding EW totaled $3.69 billion.
- Zacks•28 days ago
3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day
With World Heart Day coming up, here is a look at some well-positioned stocks including BioTelemetry (BEAT) in this segment of the market.
- Zacks•29 days ago
Allscripts Rides High on Product Launches Amid Rising Costs
Management at Allscripts Healthcare (MDRX) is focused on various restructuring initiatives, research and development plans and launch of exclusive products.
- Zacks•29 days ago
Edwards Lifesciences, Bed Bath & Beyond, Annaly Capital Management, AGNC Investment and ARMOUR Residential REIT highlighted as Zacks Bull and Bear of the Day
Edwards Lifesciences, Bed Bath & Beyond, Annaly Capital Management, AGNC Investment and ARMOUR Residential REIT highlighted as Zacks Bull and Bear of the Day
- Zacks•29 days ago
Omnicell (OMCL) Gains on Product Launches, Global Expansion
The market is upbeat about Omnicell's (OMCL) recently-launched XT Series Automated Supply Dispensing Cabinet. The company is also expanding its footprint globally.
- Zacks•29 days ago
Align Technology (ALGN) Prospects Bright, Competition Rife
Align Technology (ALGN) continues to gain from strong InvisAlign sales amid macroeconomic headwinds.
